$AUPH

Here's another Co that is accelerating revenue year on year (see my previous tweets). $AUPH is changing the game in #lupus care. Its lead drug, Lupkynis, is the first FDA-approved oral therapy for lupus nephritis (LN), a severe, life-threatening disease that attacks the kidneys